# FDA recall D-1534-2014

> **Bacai Inc. Dba Ky Duyen House** · Class I · drug recall initiated 2014-04-30.

## Product

Lite Fit USA, For Men & Women, Extreme Fat Burner, Suppresses Appetite, Boosts Metabolism, Limits Fat Absorption, Increases Energy, Prevents lipid formation by limiting fat absorption  30 pills /Bottle, Distributed by: Bacai, INC. www.litefitusa.com

## Reason for recall

Marketed Without an Approved NDA/ANDA: Bacai, Inc. DBA Ky Duyen House is voluntarily recalling Lite Fit USA, lot 13165, due to undeclared sibutramine, making it an unapproved new drug.

## Distribution

Worldwide via internet sales

## Key facts

- **Recall number:** D-1534-2014
- **Recalling firm:** Bacai Inc. Dba Ky Duyen House
- **Classification:** Class I
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2014-04-30
- **Report date:** 2014-08-20
- **Termination date:** 2015-02-10

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Fountain Valley, CA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1534-2014

## Citation

> AI Analytics. FDA recall D-1534-2014. Retrieved 2026-06-16 from https://api.ai-analytics.org/recall/D-1534-2014. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*